Back to search

Article

Pathogenic ultra-rare variants in<i>SLC6A1, SLC6A11, GAD1 and GAD2</i>are new & recurrent GABAergic loci for GGE syndromes

2025-04-04

Abstract excerpt

There is a wealth of biological evidence that supports the concept that GABAergic inhibition is causal to some genetic generalized epilepsy (GGE) syndromes. Much is known about postsynaptic GABAAR channelopathies, however, the presynaptic determinants are less well-defined such as the role of GABA transporters ( SLC6A1 / GAT1; SLC6A11 / GAT3), and GABA biosynthesis biology ( GAD1 / GAD67; GAD2 / GAD65). In respons...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7dd41750-2d50-560e-9206-a618e65ab59a
DOI
10.1101/2025.04.01.24316792
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pathogenic ultra-rare variants in<i>SLC6A1, SLC6A11, GAD1 and GAD2</i>are new & recurrent GABAergic loci for GGE syndromesDOI 10.1101/2025.04.01.24316792
Select a neighboring publication to make it the new centre.